News

A Mexico City startup has achieved the Western Hemisphere's first SaMD regulatory approval for its proprietary AI-powered ...
FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...
XENOVIEW™, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and ...
The FDA plans to roll out its agency-wide AI tool weeks ahead of schedule, per a press release that provides the most ...
Brain-computer interface technology shows promise in helping motor-impaired patients, like those with Lou Gehrig's disease, ...
The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...
A breakthrough nerve therapy is improving stroke survivors' mobility and quality of life. A UConn doctor is asking the state ...
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...